Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
Abroad (travel likely)RecruitingPHASE2
Conditions
Colorectal Carcinoma · Colorectal Neoplasms · Colorectal Tumor · Colorectal Adenocarcinoma · Colorectal Cancer (CRC) · Colorectal Cancer · Colon Cancer · Colon Adenocarcinoma · Colon Carcinoma · Colon Neoplasm
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
Fondazione Policlinico Universitario Agostino Gemelli, IRCCS, Roma, Italy
Contact: Study coordinator (Maria Alessandra Calegari) · mariaalessandra.calegari@policlinicogemelli.it · +39 06 30156318Ospedale Cardinale G. Panico, Tricase, Italy
Contact: Study coordinator (Emiliano Tamburini) · oncologia.trials@piafondazionepanico.it · +39 0833 773111
Study leads
Maria Alessandra Calegari
Principal Investigator
Fondazione Policlinico Universitario Agostino Gemelli IRCCS